Sanofi‘s patent describes an autoinjector featuring a syringe support that maintains the syringe’s axial position within the housing. The design includes a flexible portion to bias the syringe distally, enhancing the device’s functionality and stability during use. GlobalData’s report on Sanofi gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Sanofi, NSAID cancer drugs was a key innovation area identified from patents. Sanofi's grant share as of June 2024 was 61%. Grant share is based on the ratio of number of grants to total number of patents.
Syringe support for autoinjector device
The patent US12042636B2 describes an innovative auto-injector designed to enhance the delivery of medicaments through a syringe mechanism. The auto-injector features a housing with a longitudinal axis, a syringe carrier that supports the syringe to prevent distal movement, and a sleeve-shaped needle shroud that can be extended or retracted to cover the needle. A shroud spring biases the needle shroud distally, while a rear part of the housing engages with the syringe support to limit axial movement. The syringe support includes a flexible portion that maintains contact with the syringe's proximal flange, accommodating variations in syringe length. The design also incorporates a hollow plunger rod and a compression drive spring to facilitate the dispensing of medicament.
Additional claims detail the structural components and functionalities of the auto-injector, including the configuration of the syringe support, the progressive spring stiffness of the flexible portion, and the integration of audible indicators to signal the completion of medicament delivery. The auto-injector is designed to accommodate syringes with a nominal length of 50 mm and variations in length of up to ±1.5 mm. The assembly method for the auto-injector is also outlined, emphasizing the engagement of the rear part with the housing and the syringe support. Overall, the patent presents a comprehensive design aimed at improving the usability and effectiveness of auto-injectors in medical applications.
To know more about GlobalData’s detailed insights on Sanofi, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
